Source comparison
SS-31 versus MOTS-c
Both peptides target mitochondria but through fundamentally different mechanisms. SS-31 physically stabilizes mitochondrial membranes by binding cardiolipin. MOTS-c activates metabolic signaling pathways, particularly AMPK. MOTS-c has stronger evidence for met
This comparison does not assign a generated winner or score.
- Both peptides target mitochondria but through fundamentally different mechanisms. SS-31 physically stabilizes mitochondrial membranes by binding cardiolipin. MOTS-c activates metabolic signaling pathways, particularly AMPK.
- MOTS-c has stronger evidence for metabolic benefits including improved insulin sensitivity and glucose metabolism. It may be superior for fat loss and metabolic conditioning phases. SS-31 has stronger evidence for direct effects on ATP production and exercise tolerance.
- Cost differs significantly. MOTS-c tends to be more affordable and more widely available from research suppliers. SS-31 is generally more expensive, which factors into practical decisions about long-term use.
- The compounds work well together, addressing different aspects of mitochondrial health. Choosing between them depends on primary goals: metabolic optimization favors MOTS-c, while direct mitochondrial repair favors SS-31.